PCVX stock

Vaxcyte Inc (PCVX) financials · $6.84B cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Vaxcyte Inc (PCVX) $6.84B cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$923.7M-$569.5M
Net Income-$766.6M-$463.9M
EPS (Diluted)-$5.63-$3.80
Cached annual balance sheet
LineFY2025FY2024
Total Assets$3.00B$3.51B
Current Assets$1.63B$1.79B
Cash & Equivalents$174.0M$387.9M
PP&E$257.4M$198.0M
Total Liabilities$317.2M$205.5M
Current Liabilities$205.8M$140.2M
Shareholders' Equity$2.69B$3.31B
Retained Earnings-$2.15B-$1.39B
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$655.6M-$452.6M
CapEx$13.7M$22.4M
Investing Cash Flow$437.4M-$2.01B
Financing Cash Flow$2.01M$2.45B
Net Change in Cash-$213.8M-$9.36M
Free Cash Flow-$669.3M-$475.1M
These statements as JSON? API free 100/day

FAQ

What is PCVX P/E and revenue?

Vaxcyte Inc (PCVX) $6.84B cap.

What is PCVX revenue?

PCVX income-statement cache has no revenue figure yet.

Is PCVX profitable?

Vaxcyte Inc last cached net income is -$766.6M (FY2025).

What are PCVX total assets?

Vaxcyte Inc last cached total assets are $3.00B (FY2025).

What is PCVX free cash flow?

Vaxcyte Inc last cached free cash flow is -$669.3M (FY2025).

Not investment advice. Cached statements, not a live tape.